Australia Medical Cannabis Market Size, Share, Trends and Forecast by Species, Derivatives, Application, Route of Administration, End Use, and Region, 2025-2033

Australia Medical Cannabis Market Size, Share, Trends and Forecast by Species, Derivatives, Application, Route of Administration, End Use, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A32011

Australia Medical Cannabis Market Overview:

The Australia medical cannabis market size reached USD 740.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,373.1 Million by 2033, exhibiting a growth rate (CAGR) of 7.10% during 2025-2033. The market is driven by increasing government approvals, rising patient demand for alternative treatments, expanding research on therapeutic benefits, and growing investment in domestic cannabis production. Improved accessibility, physician acceptance, and evolving regulations further contribute to the Australia medical cannabis market growth.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024 USD 740.0 Million
Market Forecast in 2033 USD 1,373.1 Million
Market Growth Rate 2025-2033 7.10%


Australia Medical Cannabis Market Trends:

Increasing Government Approvals and Regulatory Support

The Australian government has progressively eased restrictions on medical cannabis, making it more accessible to patients. The Therapeutic Goods Administration (TGA) allows medical cannabis prescriptions under the Special Access Scheme (SAS) and Authorised Prescriber pathways, which is positively impacting the Australia medical cannabis market outlook. The expansion of legal frameworks has fueled doctor willingness to prescribe cannabis-based medicated treatments leading to industry development. The medical cannabis industry continues to advance through rules established at the state level which enhance patient access. The market is expected receive a boost from policymakers who understand cannabis' medical capabilities by quickly approving new products along with better regulations. Government support for Australia's medical cannabis industry will enhance both industrial development and medication distribution and technological advancements. For instance, in September 2024, a global leader in medical cannabis, Tilray Medical, a division of Tilray Brands, Inc., declared the introduction of Redecan EU-GMP-certified medical cannabis products in Australia. This partnership enables patients and healthcare professionals to make well-informed, personalized health decisions. Australia’s supportive regulatory framework is enabling more global medical cannabis brands to enter the market, reinforcing the trend of increased accessibility and acceptance of cannabis-based treatments.

Australia Medical Cannabis Market Size

Rising Patient Demand for Alternative Treatments

Patients suffering from chronic pain, epilepsy, anxiety, multiple sclerosis, and cancer-related symptoms are increasingly turning to medical cannabis as an alternative or complementary therapy. Traditional pharmaceuticals often come with side effects or limited effectiveness, leading many to seek cannabis-based treatments for pain relief, inflammation, and neurological conditions. Greater awareness of CBD (cannabidiol) and THC (tetrahydrocannabinol) benefits, along with patient advocacy, has driven demand, which is fueling the Australia medical cannabis market share. As more Australians explore natural, plant-based medicines, the demand for prescription cannabis products continues to surge, encouraging growth in the sector. This rising acceptance is prompting companies to scale operations and explore regional expansion to meet growing patient needs. For instance, in February 2025, Dispensed, a leading Australian medicinal cannabis company announced its plans to launch New Zealand operations, utilizing kiosks in various locations such as pharmacies and clinics. As patient trust in cannabis-based therapies continues to build, the sector is expected to see sustained momentum, reinforcing the upward trajectory of the Australia medical cannabis market.

Australia Medical Cannabis Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional level for 2025-2033. Our report has categorized the market based on species, derivatives, application, route of administration, and end use.

Species Insights:

  • Indica
  • Sativa
  • Hybrid

The report has provided a detailed breakup and analysis of the market based on the species. This includes indica, sativa, and hybrid.

Derivatives Insights:

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Others

A detailed breakup and analysis of the market based on the derivatives have also been provided in the report. This includes cannabidiol (CBD), tetrahydrocannabinol (THC), and others.

Application Insights:

Australia Medical Cannabis Market By Application

  • Cancer
  • Arthritis
  • Migraine
  • Epilepsy
  • Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes cancer, arthritis, migraine, epilepsy, and others.

Route of Administration Insights:

  • Oral Solutions and Capsules
  • Vaporizers
  • Topicals
  • Others

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral solutions and capsules, vaporizers, topicals, and others.

End Uses Insights:

  • Pharmaceutical Industry
  • Research and Development Centres
  • Others

A detailed breakup and analysis of the market based on the end uses have also been provided in the report. This includes the pharmaceutical industry, research and development centers, and others.

Regional Insights:

  • Australia Capital Territory & New South Wales
  • Victoria & Tasmania
  • Queensland
  • Northern Territory & Southern Australia
  • Western Australia

The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Australia Medical Cannabis Market News:

  • In Oct 2024, Spring Sciences Australia (SSA) announced its partnership with Canngea to supply up to 5 tons of premium organic medicinal cannabis products, enhancing local availability. This groundbreaking agreement aims to meet rising demand in Australia’s cannabis market by offering high-quality, pharmaceutical-grade alternatives to imported goods, leveraging both companies' strengths. .
  • In December 2024, Aurora Cannabis Inc. announced its partnership with The Entourage Effect to enhance distribution in Australia, making MedReleaf Australia's premium medical cannabis products more accessible. This collaboration aims to support patient care while strengthening Aurora's presence in the growing Australian market, leveraging MedReleaf’s TGA-GMP compliance for quality assurance.

Australia Medical Cannabis Market Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Scope of the Report

Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:

  • Species
  • Derivatives
  • Application
  • Route of Administration
  • End Use 
  • Region
Species Covered Indica, Sativa, Hybrid
Derivatives Covered Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others
Applications Covered Cancer, Arthritis, Migraine, Epilepsy, Others
Route of Administrations Covered Oral Solutions and Capsules, Vaporizers, Topicals, Others
End Uses Covered Pharmaceutical Industry, Research and Development Centers, Others
Regions Covered Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, Western Australia
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the Australia medical cannabis market performed so far and how will it perform in the coming years?
  • What is the breakup of the Australia medical cannabis market on the basis of species?
  • What is the breakup of the Australia medical cannabis market on the basis of derivatives?
  • What is the breakup of the Australia medical cannabis market on the basis of application?
  • What is the breakup of the Australia medical cannabis market on the basis of route of administration?
  • What is the breakup of the Australia medical cannabis market on the basis of end use?
  • What is the breakup of the Australia medical cannabis market on the basis of region?
  • What are the various stages in the value chain of the Australia medical cannabis market? 
  • What are the key driving factors and challenges in the Australia medical cannabis?
  • What is the structure of the Australia medical cannabis market and who are the key players?
  • What is the degree of competition in the Australia medical cannabis market? 

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Australia medical cannabis market from 2019-2033.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the Australia medical cannabis market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Australia medical cannabis industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Australia Medical Cannabis Market Size, Share, Trends and Forecast by Species, Derivatives, Application, Route of Administration, End Use, and Region, 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials